We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.95%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.85B
AUM Growth
-$38.7M
Cap. Flow
-$602M
Cap. Flow %
-21.14%
Top 10 Hldgs %
27.89%
Holding
132
New
16
Increased
23
Reduced
29
Closed
17

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$55.3M
2
XERS icon
Xeris Biopharma Holdings
XERS
+$48.6M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$41.7M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$27.9M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$27.7M

Top Sells

Rank Stock Value
1
AVXS
AveXis, Inc. Common Stock
AVXS
+$93.4M
2
DXCM icon
DexCom
DXCM
+$41M
3
DVA icon
DaVita
DVA
+$32.1M
4
GSK icon
GSK
GSK
+$31.6M
5
VTRS icon
Viatris
VTRS
+$31.6M

Sector Composition

Rank Sector Weight
1 Healthcare 73.94%
2 Financials 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADVM
101
DELISTED
Adverum Biotechnologies
ADVM
– –
-42,200
Closed -$2.45M
DVA icon
102
DaVita
DVA
$15.2B
– –
-486,427
Closed -$32.1M
GSK icon
103
GSK
GSK
$104B
– –
-648,000
Closed -$31.6M
GYRE icon
104
Gyre Therapeutics
GYRE
$675M
– –
-110,747
Closed -$21.4M
IFRX icon
105
InflaRx
IFRX
$273M
– –
-88,500
Closed -$2.55M
MCK icon
106
McKesson
MCK
$98.5B
– –
-150,000
Closed -$21.1M
PODD icon
107
Insulet
PODD
$11.4B
– –
-171,000
Closed -$14.8M
HIND
108
Vyome Holdings
HIND
$15.1M
– –
0
– -$1.53M
SCYX icon
109
SCYNEXIS
SCYX
$42.4M
– –
-12,750
Closed -$1.37M
TCMD icon
110
Tactile Systems Technology
TCMD
$648M
– –
-91,020
Closed -$2.89M
VYNE icon
111
VYNE Therapeutics
VYNE
$25.4M
– –
-5,927
Closed -$16M
SCTL
112
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
– –
-1,126,150
Closed -$11.1M
PTLA
113
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-500,000
Closed -$16.3M
PTLA
114
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-500,000
Closed -$16.3M
TSRO
115
DELISTED
TESARO, Inc.
TSRO
– –
-42,893
Closed -$2.45M
EGLT
116
DELISTED
Egalet Corporation
EGLT
– –
-3,239,237
Closed -$2.04M
ARMO
117
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
– –
-188,525
Closed -$7.05M
AVXS
118
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-755,798
Closed -$93.4M
1 2 3 4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q2 2018 Portfolio in Review

As of Q2 2018, Deerfield Management held 132 positions worth $2.85B, down 1.3% from $2.89B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Deerfield Management withdrew a net $602M in Q2 2018, closing 17 positions and reducing 29 holdings. Its most notable exit was AveXis, Inc. Common Stock, an estimated $93.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 75% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Portola Pharmaceuticals, Inc. worth $54.6M.

  • Deerfield Management's largest Q2 2018 buy was Portola Pharmaceuticals, Inc.: 1,446,633 shares worth $54.6M.
  • Deerfield Management added most to Mirati Therapeutics, Inc. Common Stock in Q2 2018, an estimated $41.7M increase.
  • Deerfield Management's biggest Q2 2018 reduction was DexCom, cutting an estimated $41M.
  • Deerfield Management fully exited AveXis, Inc. Common Stock in Q2 2018, selling an estimated $93.4M.
  • Deerfield Management's ten largest holdings make up 28% of its $2.85B portfolio in Q2 2018.
  • Deerfield Management opened 16 new positions and closed 17 in Q2 2018.
  • Deerfield Management's portfolio value fell 1.3% quarter-over-quarter to $2.85B.

Based on Deerfield Management's 13F filing for Q2 2018, filed 14 Aug 2018.